About US
Contact us
-
A New Formulation Line for Insulin VialsThe Danish pharmaceutical group Novo Nordisk has chosen Bürkert, the fluid control specialists, to equip its latest production line for the formulation of insulin vials at its site in Chartres, France2014/11/7
-
Roche’s Basel Site Expansion, Basel, SwitzerlandRoche, the world's fourthbiggest pharmaceutical companyof 2014, announced its investment plans on a major infrastructure development project at its Basel site in Switzerland in October 2014. The deve2014/11/6
-
BMS signs exclusive option deal to buy Danish Galecto BiotechBristol-Myers Squibb (BMS) has entered into an exclusive option agreement to acquire Denmark-based Galecto Biotech and receive worldwide rights to its inhaled inhibitor of galectin-3, TD139. Galectin2014/11/6
-
Astellas and Proteostasis partner to develop therapeutic candidates for UPRJapan-based Astellas Pharma has partnered with Proteostasis Therapeutics for research, development and commercialisation of therapies, which modulate the unfolded protein response (UPR). Under the de2014/11/6
-
Bayer acquires Chinese Dihon Pharmaceutical for €460mGermany-based Bayer has completed the acquisition of China-based Dihon Pharmaceutical Group, for CNY3.6bn (€460m). Dihon produces over-the-counter (OTC) dermatology products and herbal traditional Ch2014/11/5
-
Pharming and Salix introduce acute angioedema treatment Ruconest in USPharming Group and Salix Pharmaceuticals have introduced Ruconest (C1 esterase inhibitor [recombinant]) 50IU/kg in the US, a treatment developed to treat acute angioedema attacks in adult and adolesce2014/11/5
-
Arena narrows loss as Belviq sales pick upArena Pharmaceuticals ($ARNA), developer of the weight-loss drugBelviq, is not exactly getting fat off of its sales, but it is making progress. With a marketing push from partnerEisaibehind it, the dr2014/11/5
-
Eleventh API China pharmaceutical excipients ForumEleventh API China pharmaceutical excipients Forum Pharmaceutical excipients and food additives’ quality standard seminar Time: November 28, 2014 9: 00-16: 30 Venue: China Import and Export Fa2014/11/5
-
2014'PHEXTOUR– Zhuhai Station2014'PHEXTOUR Pharmaceutical Excipients Application Technology (Greater China) Tour Seminars– Zhuhai Station Publisher: phexcom Published: 2014/10/28 10:42:08 2014'PHEXTOUR Pharmaceutical Excipie2014/11/4
-
Bristol-Myers Squibb expands biologics manufacturing agreement with LonzaBristol-Myers Squibb (BMS) has expanded its existing biologics manufacturing agreement with Switzerland-based Lonza. The contract is expanded for the production of commercial quantities of a second B2014/11/4